1. [Identification by PCR and antifungal susceptibility of vaginal clinical Candida sp isolates].
- Author
-
Alves IA, Camargo FP, and Goulart LS
- Subjects
- Amphotericin B pharmacology, Candida genetics, Candida isolation & purification, DNA, Fungal analysis, Female, Fluconazole pharmacology, Humans, Microbial Sensitivity Tests, Polymerase Chain Reaction, Pyrimidines pharmacology, Triazoles pharmacology, Voriconazole, Antifungal Agents pharmacology, Candida drug effects, Candidiasis, Vulvovaginal microbiology
- Abstract
Introduction: Vaginal candidiasis is a condition that affects innumerous fertile women. Candida albicans is the most frequently isolated species from vaginal discharge; however, other different species that are more resistant to antifungal drugs can be identified in vaginal clinical samples., Methods: The species of 30 vaginal Candida isolates was identified by PCR using the universal ITS4 primer and species-specific primers for C. albicans, C. glabrata, C. tropicalis and C. krusei. The sensitivity pattern to amphotericin B, fluconazole and voriconazole was assessed using the CLSI M27-A2 macrodilution method., Results: The PCR assay revealed 28 C. albicans and 2 samples showed amplification for C. albicans and C. glabrata primers. The minimum inhibitory concentration for amphotericin B ranged from 0.03 µg/mL to 0.25 µg/mL, for fluconazole from 0.125 µg/ml to 16 µg/mL and for voriconazole from 0.03 µg/mL to 0.25 µg/m., Conclusions: Identification at Candida species level by PCR assay could be relevant for clinical management of these infections.
- Published
- 2010
- Full Text
- View/download PDF